Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.39
+0.43 (4.80%)
At close: Mar 9, 2026, 4:00 PM EDT
9.35
-0.04 (-0.43%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
8299046771,068847932
Upgrade
Market Cap Growth
29.27%33.48%-36.58%26.07%-9.08%-56.80%
Upgrade
Enterprise Value
183374239633425396
Upgrade
Last Close Price
9.3910.398.7114.3812.4114.00
Upgrade
PS Ratio
12.2913.4012.57---
Upgrade
PB Ratio
4.745.191.642.692.021.84
Upgrade
P/TBV Ratio
4.765.191.642.692.021.84
Upgrade
P/FCF Ratio
--5.06---
Upgrade
P/OCF Ratio
--5.04---
Upgrade
EV/Sales Ratio
2.715.544.43---
Upgrade
EV/FCF Ratio
--1.78---
Upgrade
Debt / Equity Ratio
0.120.120.040.040.030.01
Upgrade
Debt / FCF Ratio
--0.12---
Upgrade
Net Debt / Equity Ratio
-3.71-3.71-1.72-1.02-1.01-1.01
Upgrade
Net Debt / EBITDA Ratio
2.142.143.702.473.053.91
Upgrade
Net Debt / FCF Ratio
9.159.15-5.313.253.834.84
Upgrade
Asset Turnover
0.090.090.09---
Upgrade
Quick Ratio
5.815.819.3112.0518.2423.13
Upgrade
Current Ratio
6.066.069.4612.2618.5623.26
Upgrade
Return on Equity (ROE)
-94.82%-94.82%-42.91%-37.34%-29.31%-23.35%
Upgrade
Return on Assets (ROA)
-25.33%-25.33%-19.97%-22.89%-17.65%-13.89%
Upgrade
Return on Capital Employed (ROCE)
-48.90%-48.90%-28.40%-40.10%-32.40%-25.70%
Upgrade
Earnings Yield
-33.60%-30.82%-25.69%-14.29%-16.04%-14.00%
Upgrade
FCF Yield
-8.52%-7.82%19.76%-11.70%-13.07%-11.34%
Upgrade
Buyback Yield / Dilution
-1.76%-1.76%-17.66%-9.31%-0.96%-25.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.